⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132643 | 1.00 | — | — | |
| SCHEMBL2328444 | 1.00 | — | — | |
| Ethylene Glycol SCHEMBL29006093 | 0.94 | OR51E2 (0.39) | — | |
| Acetic Acid SCHEMBL3888013 | 0.92 | OR51E2 (0.50) | — | |
| Phosphoric Acid SCHEMBL8540518 | 0.87 | OR51E2 (0.40) | — | |
| Dimethyl Sulfoxide SCHEMBL9985876 | 0.87 | OR51E2 (0.35) | — | |
| Butyl Alcohol SCHEMBL6233982 | 0.83 | ALDH1A1 (0.48) | — | |
| Methacrylic Acid SCHEMBL10932249 | 0.83 | OR51E2 (0.42) | — | |
| Acrylic Acid SCHEMBL4814346 | 0.82 | LMNA (0.42) | — | |
| SCHEMBL1331108 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120737119-A | Preparation method of L-alpha-phosphorylcholine azole | 拓新药业集团股份有限公司 | 2025-10-03 | — | — | CN | disclosed |
| US-20250084116-A1 | MIXTURE OF STEREOISOMERS OF A SULFATED GLYCOLIPID | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-03-13 | — | — | US | disclosed |
| EP-4460328-A1 | MIXTURE OF STEREOISOMERS OF A SULFATED GLYCOLIPID | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2024-11-13 | — | — | EP | disclosed |
| US-10266565-B2 | Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2019-04-23 | — | — | US | disclosed |
| US-9175038-B2 | Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2015-11-03 | — | — | US | disclosed |
| US-20140142044-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | The United States of America, as represented by the Secretary, Department of Health & Human Servic (US) | 2014-05-22 | — | — | US | disclosed |
| US-20120065146-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH (US) | 2012-03-15 | — | — | US | disclosed |
| EP-1838283-B1 | LIPID-BASED DRUG DELIVERY SYSTEMS CONTAINING UNNATURAL PHOSPHOLIPASE A2 DEGRADABLE LIPID DERIVATIVES AND THE THERAPEUTIC USES THEREOF | LIPLASOME PHARMA AS (DK) | 2008-12-31 | — | — | EP | disclosed |
| US-20080014253-A1 | Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof | LIPLASOME PHARMA A/S (DK) | 2008-01-17 | — | — | US | disclosed |
| EP-1838283-A2 | LIPID-BASED DRUG DELIVERY SYSTEMS CONTAINING UNNATURAL PHOSPHOLIPASE A2 DEGRADABLE LIPID DERIVATIVES AND THE THERAPEUTIC USES THEREOF | Liplasome Pharma A/S (DK) | 2007-10-03 | — | — | EP | disclosed |
| US-6829540-B1 | Data processing, drug screening using immobilized artificial membrane chromatographic substrates in high pressure liquid chromatographic systems using aqueous mobile phases | PURDUE RESEARCH FOUNDATION | 2004-12-07 | — | — | US | disclosed |
| WO-2004092188-A2 | ANALOGS OF LYSOPHOSPHATIDIC ACID AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2004-10-28 | — | — | WO | disclosed |
| EP-0634408-B1 | DEPSIPEPTIDE DERIVATIVE, PRODUCTION THEREOF AND USE THEREOF | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1015623-A1 | DRUG DISCOVERY USING MULTIPLE MEMBRANE MIMETIC AFFINITIES | PURDUE RESEARCH FOUNDATION (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999010522-A1 | DRUG DISCOVERY USING MULTIPLE MEMBRANE MIMETIC AFFINITIES | PURDUE RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | disclosed |
| CN-1039331-C | Depsispeptide derivative, preparation and application of same | FUJISAMA PHARMACEUTICAL CO LTD (JP) | 1998-07-29 | — | — | CN | disclosed |
| US-5514773-A | PARASITICIDES, ANTHELMINTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-07 | — | — | US | disclosed |
| EP-0634408-A1 | DEPSIPEPTIDE DERIVATIVE, PRODUCTION THEREOF AND USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-01-18 | — | — | EP | disclosed |
| CN-1080932-A | Depsipeptide derivative and manufacture method thereof and purposes | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-01-19 | — | — | CN | disclosed |
| WO-1993001196-A1 | KETOALKYLGLYCEROPHOSPHOLIPIDS HAVING ANTITUMOR AND ANTI-PLATELET AGGREGATION ACTIVITIES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREFROM | LABORATORIOS MENARINI S.A. (ES) | 1993-01-21 | — | — | WO | disclosed |